Showing results (1251-1260 of 7,557) with videos related to

Sort By:
Pageof 756
Molecular Pharmaceutics|October 8, 2014
Gambogic acid-loaded electrosprayed particles for site-specific treatment of hepatocellular carcinomaDengke Yin, Ye Yang, Hanxu Cai, et al.
Molecular Pharmaceutics|September 23, 2014
Therapeutic aerosol bioengineering of siRNA for the treatment of inflammatory lung disease by TNFα gene silencing in macrophagesCiara Kelly, Awadh B Yadav, Ciaran Lawlor, et al.
Molecular Pharmaceutics|July 15, 2014
Multifunctional cationic lipid-based nanoparticles facilitate endosomal escape and reduction-triggered cytosolic siRNA releaseManeesh Gujrati, Anthony Malamas, Tesia Shin, et al.
Molecular Pharmaceutics|September 6, 2014
Role of the phospholipase A2 receptor in liposome drug delivery in prostate cancer cellsN D Quach, J N Mock, N E Scholpa, et al.
Molecular Pharmaceutics|September 6, 2014
Overexpression of human ABCB1 in cancer cells leads to reduced activity of GSK461364, a specific inhibitor of polo-like kinase 1Chung-Pu Wu, Sung-Han Hsiao, Shi-Yu Luo, et al.
Molecular Pharmaceutics|September 9, 2014
Transport pathways of solid lipid nanoparticles across Madin-Darby canine kidney epithelial cell monolayerGui-Hong Chai, Fu-Qiang Hu, Jihong Sun, et al.
Molecular Pharmaceutics|September 25, 2014
Biocompatible and mucoadhesive bacterial cellulose-g-poly(acrylic acid) hydrogels for oral protein deliveryNaveed Ahmad, Mohd Cairul Iqbal Mohd Amin, Shalela Mohd Mahali, et al.
Molecular Pharmaceutics|September 26, 2013
Enhanced brain delivery of deferasirox-lactoferrin conjugates for iron chelation therapy in neurodegenerative disorders: in vitro and in vivo studiesGolnaz Kamalinia, Fariba Khodagholi, Fatemeh Atyabi, et al.
Molecular Pharmaceutics|October 2, 2013
A novel SERCA inhibitor demonstrates synergy with classic SERCA inhibitors and targets multidrug-resistant AMLNicholas P Bleeker, Razvan L Cornea, David D Thomas, et al.
Molecular Pharmaceutics|October 2, 2013
Combined in vitro-in vivo approach to assess the hepatobiliary disposition of a novel oral thrombin inhibitorElin M Matsson, Ulf G Eriksson, Johan E Palm, et al.
Pageof 756